Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

drug launch

This page shows the latest drug launch news and features for those working in and with pharma, biotech and healthcare.

Sanofi, Regeneron launch trials of arthritis drug Kevzara for COVID-19

Sanofi, Regeneron launch trials of arthritis drug Kevzara for COVID-19

Encouraged and spurred on by the initial efficacy of Actemra, Kevzara’s owners are carrying out their own trials of the drug as a treatment for the novel coronavirus, with Regeneron ... 16 sites and evaluating the drug’s effect on fever and

Latest news

More from news
Approximately 1 fully matching, plus 203 partially matching documents found.

Latest Intelligence

  • Reaching patients and HCPs during the pandemic Reaching patients and HCPs during the pandemic

    Nexlizet, and Esperion was even able to accelerate the launch of the therapy by one month. ... While Horizon was fortunate enough to launch its bulging eye drug, Tepezza, in January 2020, the pandemic still hit at a critical time for any new drug.

  • Successful product commercialisation: what can we learn from the rare disease setting? Successful product commercialisation: what can we learn from the rare disease setting?

    Achieving launch success in an increasingly challenging commercial environment. The pharmaceutical industry is constantly evaluating opportunities to accelerate product life cycles and bring efficiencies to drug discovery, development and

  • Alzheimer’s: the search for a cure Alzheimer’s: the search for a cure

    However, the situation has changed dramatically since then, with Biogen preparing for a drug launch that could make aducanumab a blockbuster and reinvigorate interest in amyloid beta. ... A lot is resting on the US Food and Drug Administration’s (FDA)

  • Cooking up a co-creation feast – beyond vanilla Cooking up a co-creation feast – beyond vanilla

    Another challenge for us as agencies is to nudge our clients to involve the end user earlier and earlier in the drug development process. ... Often, we co-design material to support the use of a drug during its clinical development.

  • Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019 Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019

    This year’s report additionally features insight from the new Cortellis Analytics – Drug Timeline &Success Rates module, an analytic that predicts the probability of launch and timeline to market for ongoing ... The company expects to launch the drug

More from intelligence
Approximately 1 fully matching, plus 17 partially matching documents found.

Latest appointments

  • NDA Group appoints Alison McGregor as its principal consultant NDA Group appoints Alison McGregor as its principal consultant

    She joins the group following a new US office launch. Drug development consultancy, NDA Group, has appointed Alison McGregor as its principal consultant following the opening of its new US office

  • Medicines Discovery Catapult appoints CEO Medicines Discovery Catapult appoints CEO

    Chris' experience of leading companies operating in life sciences combined with his in-depth knowledge of drug discovery will be of tremendous value to the company.”. ... The Catapult will engage the UK's experienced drug discovery talent and help

  • Astellas promotes John Demaree Astellas promotes John Demaree

    Demaree was promoted from his position as executive director of oncology marketing, where he oversaw the launch of prostate cancer drug Xtandi (enzalutamide) and promotion of lung cancer therapy Tarceva (erlotinib).

  • Paolo Paoletti named as executive chairman of Kesios Paolo Paoletti named as executive chairman of Kesios

    Paoletti was formerly the first appointed president of GSK Oncology, where he was responsible for the overall oncology business within the firm and oversaw activities from early drug discovery through to ... clinical development, launch and life cycle

  • Purdue looks to Merck for new CEO Purdue looks to Merck for new CEO

    His previous roles include president of Merck US, during which time he helped to launch the hepatitis C drug Victrelis (boceprevir) and led the acquisition of ophthalmology company Inspire Pharmaceuticals.

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?
The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.
Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....

Quick links

Infographics

Multimedia